providing Good morning an of XXXX and review thank the third $XX.X million, the you our for XX% of operational to by XXXX. before conclude performance our was will of financial by Q&A. turning I'll joining quarter update. Total over for Steve balance thoughts then I'll up an overview begin and third results with Revenue the us. quarter followed
the see we progress the in direction. the of and we to are moving right in top into our place initiatives growth initiatives conversion into slowed to The in has continuing primarily been have strategic business many While believe line underlying due put are trends of COVID.
equipment System On of the by increased NeuroStar quarter XXXX. Therapy side, third X% capital US over the Advanced revenue
productive beginning time to the team Our continue year. the be our assumption that through launched progress at we in of begin commercial the and to at the year the would balance quarter second the was organization the of
two to have than expansion longer in our we largest pipeline focused efforts. was this slower growth, providers into anticipated a the than expansion shown support by sales We accounts than Although, the quarter a fundraising of expected experienced cycle. anticipated on expansion accounts as national result were year new as slower
a and Greenbrook accounts like TMS we national TMS. large As reminder, as Success providers define
in XXXX and to accounts, I in plans these continue support closely and believe position are teams work with to Our growth national we good their beyond. a
the impacted XX% patient was start. believe by the over growth, XXXX. performance by quarter the treatment US Our session Despite COVID new headwinds delaying we third of revenue increased
healing the In TMS providers, and exclusive In we Advanced five multiple partnerships In leading announced a Zion one services. agreement, October, Now behavioral months, health. nation's recent agreement announced year franchisor we the Therapy our adoption operational commercial design commercial leaders contract and September, turning we will effort be an of the mental TMS, Healing, with accelerate on exclusive leading TMS its with in the in In extension of a NeuroStar to with this of Success space franchisees. equipment, one have to highlights. Neuronetics of announced for longest supplier a of accounts. TMS standing
As part exclusively systems System agreement, NeuroStar of will treat health this suffering utilize Success treatment to our mental resistant depression. for TMS Therapy Advanced patients from
River part signed loan coming a the October, Region a their a southeastern TMS provider $XX in leading River the of the term in commercial United As plans support States. extension, agreement secured we we Also over million made year. to with expansion re Psychiatry,
systems. We are TMS excited to exclusive for supplier been have their chosen as
XXXX in River executing We Region in team to our plans their beyond. expansion prepared and have assist
September, on we to attended practice the to with in-depth to accounts. was and well The update event, our events of NeuroStar over offer. Turning event November. Chicago. was opportunity And subsequently; second another scheduled and our opportunities. growth event continue managers put have an customers, we including to to expand partnership the sales offer our a physicians XX In capital This over an event from at the various review several marketing these and summit seven an the hosted provide calendar them programs of in we'll expect practice We number support we we on for closed initiatives.
their new identify our X-STARS practices these believe a within In are customers, to our patients. significant opportunity recently Pulse drug interested NeuroStar patients. authorization Precision designed will process, Over additional become investment XXX we earlier for to more without able programs meet their a points tool non Utilizing their their a any proprietary we in we NeuroStar to in existing help the over the candidates patients several we and addition as who treatment in are launched help program were screening tool, to part. practices our base better for patients therapy. patients a a The programs, on our who patients outcomes pre new customer practices identify piloted depression year, success of and the many be criteria the to deliver within to to work way through NeuroStar time,
an paper a lower with treatment than the from seizure Recently, our regulatory we the that work survey struggles progress. what patient's H-Coil half NeuroStar on have a an a to with published system Advanced and titled TMS clinical Risk Therapy I in peer results market. TMS important supports of provide we with and update effective Seizure most was Lastly, doing over solve that mental Stimulation, treatments paper to million with The the further on technology. risk believe with published health for reviewed a stimulation a safest claim deeper was showed sessions mental health repetitive Brain which patients want is are significantly
dialogue the FDA our additional an potential our recent We and clearance label regarding indication. expansion with with are encouraged for
the the initiatives control, below exact of drive are decision While and have We to timing expectations. quarter future discussions are the our growth. with performance make is to believe FDA progress in our this continuing moving right of we revenue In was believe that to productive agency continue we summary, our direction. our the out strategic while we on
provide continue the the health. Advanced and to to I'd overview. identify work drive expand now to efforts drive turn our call seek of Therapy our patients adoption ways optimize to awareness, to to NeuroStar for financial and out and broader mental We to with educate Steve like over existing customers